Alexander Sultanbaev

3PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 04, 2025
Real-world outcomes of lenvatinib plus pembrolizumab in intermediate- and poor-risk metastatic renal cell carcinoma.

Ilya Tsimafeyeu, Alexander Sultanbaev, Daria Dubovichenko

|Dec 01, 2023
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent.

Radmir R Rakhimov, Aleksandr V Sultanbaev, Adel A Izmailov

Pageof 1